Maxim Group initiated coverage on shares of Medicus Pharma (NASDAQ:MDCX – Get Free Report) in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage set a “buy” rating and a $10.00 price target on the stock. Maxim Group’s price target points to a potential upside of 238.98% from the company’s previous close.
Medicus Pharma Stock Performance
NASDAQ MDCX opened at $2.95 on Tuesday. Medicus Pharma has a 1-year low of $1.80 and a 1-year high of $6.00.
Medicus Pharma Company Profile
Read More
- Five stocks we like better than Medicus Pharma
- How to buy stock: A step-by-step guide for beginners
- 3 Dividend Leaders Set for Strong Growth in 2025
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 3 Stocks to Gain From Stockpiling Effects of the Trump Tariffs
- P/E Ratio Calculation: How to Assess Stocks
- These 3 Stocks Look to Power AI Data Centers With Natural Gas
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
